Starfinder

Investment decisions are made by the partnership group led by Managing Partners Piotr Pietrzak and Ula Nairne. Pietrzak has a track record of seed investments through his role at StartVenture@Poland, while Nairne brings international strategic consulting experience from the UK and Liechtenstein. The Investment Director, Aleksander Mokrecki, manages pipeline generation and acquisition, supported by Senior Associate Admir Berbiu.

Starfinder relies on a network of technology brokers and diaspora connections across Central and Eastern Europe, the Balkans, and Polish hubs abroad. Venture Partner Maciej Sadowski co-founded the Startup Hub Poland Foundation, which acts as a funnel for high-tech founders. The firm also draws on the Israeli-Polish venture ties of Venture Partner Marek Borzestowski, previously of Giza Polish Ventures.

The NCBR Bridge Alfa program is a Polish public initiative that co-finances seed and early-stage venture capital funds to stimulate innovation. Starfinder combines its private capital with this public funding to invest in projects that have strong intellectual property but are often too early or technically risky for conventional VC funds. The program provides matching capital alongside private commitments.

Starfinder focuses on three primary verticals: life science, ICT, and engineering. Within life science, the firm has backed companies developing AI-driven surgical software and biotechnology platforms. Its ICT and engineering interests center on defendable intellectual property in software and advanced industrial applications.

While Starfinder is headquartered in Poland and is anchored to the Polish innovation ecosystem, its mandate covers the broader Central and Eastern European (CEE) region and the Baltic Sea area. The team's network extends to the Balkan states and diaspora communities, enabling cross-border sourcing and support for portfolio companies aiming for global markets.

Starfinder operates as the managing entity of the StartVenture@Poland 2 vehicle, a successor to the original Bridge Alfa seed fund that the same team previously ran. The investment team, including Piotr Pietrzak and Maciej Sadowski, moved their track record and strategy into the Starfinder brand while maintaining the same public-private partnership model supervised by Poland's financial regulator, KNF.

The firm has publicly noted that two of its biotechnology portfolio companies achieved listings on a stock exchange, though it has not disclosed specific names or dates beyond an April 2018 announcement referencing the Nanogroup of companies. No further exit details are publicly available.